Low concentrations (1-3 ,Ag/ml) of 5-bromodeoxyuridine (BrdU) have been shown to suppress reversibly the pigmentation in a highly pigmented clone (B559) of cultured B16 mouse melanoma cells. We have studied the effects of BrdU on tyrosinase activity in asynchronous cultures growing in medium containing 3 ,ug of BrdU/ml for up to 7 days. Culture with BrdU resulted in a reduction of both particulate-and soluble-tyrosinase activity, with as little as 1 day of culture in the presence of BrdU, and it decreased progressively with continued exposure, approaching zero by 7 days. This reduction by BrdU was partially attributable to the appearance of inhibitory material in extracts of treated cultures. Dialysis removed the inhibitory material, revealing increased units of tyrosinase activity. Our data on dialyzed extracts, however, indicated that the direct effect of the inhibitory material on tyrosinase activity was quantitatively minor compared to the total decrease in activity in BrdU-treated cultures. No detectable tyrosinase activity was found in undialyzed or dialyzed extracts of amelanotic cells produced by continuous growth in medium containing 1 ,ug of BrdU/ml, but extracts of these cells contained a dialyzable, heat-stable inhibitor of both dopa autoxidation and tyrosinase activity. The effects of BrdU on the multiple forms of soluble tyrosinase were studied by acrylamide gel electrophoresis. Bands of dopa-reactive material corresponding in Rx values to the T1 and T2 forms of tyrosinase were detected. Both forms were progressively reduced during growth in BrdU, but the T, form was consistently affected earlier than T2. Collaborative ultrastructural-cytochemical studies showed that the reduction of tyrosinase activity by BrdU was coordinated with suppression of melanosome formation. ' These data are being published elsewhere in detail (Wrathall, J. R., Oliver, C., Silagi, S., and Essner, E., Suppression of pigmentation in mouse melanoma cells by 5-bromodeoxyuridine. Effects on tyrosinase activity and melanosome formation.
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